P&PAULSON & CO. INC.
Institutional investor · Portfolio as of Q3 2020
Top Holdings31 positions
HORIZON THERAPEUTICS PUB L | 6.7M | $519.8M | 16.2% | — | — | 5 qtrssince 2019-Q3 | Decreased 0 |
BAUSCH HEALTH COS INC | 25.8M | $401.5M | 12.5% | $21.16 | -26.56% | 5 qtrssince 2019-Q3 | Unchanged 0 |
SPDR GOLD TR | 1.9M | $335.5M | 10.5% | $141.06 | +25.56% | 5 qtrssince 2019-Q3 | Unchanged 0 |
NOVAGOLD RESOURCES INC | 22.2M | $264.3M | 8.2% | $6.24 | +90.61% | 5 qtrssince 2019-Q3 | Unchanged 0 |
ACADIAN ASSET MANAGEMENT INC | 20M | $258M | 8.0% | $9.52 | +33.70% | 5 qtrssince 2019-Q3 | Unchanged 0 |
TAKEDA PHARMACEUTICAL CO LTD | 11.3M | $201.5M | 6.3% | $16.10 | +3.72% | 5 qtrssince 2019-Q3 | Decreased 0 |
| 7M | $184M | 5.7% | $4.23 | +4.12% | 5 qtrssince 2019-Q3 | Unchanged 0 | |
MYLAN NV | 11.5M | $170.2M | 5.3% | — | — | 5 qtrssince 2019-Q3 | Unchanged 0 |
DISCOVERY INC-C | 6.9M | $135.3M | 4.2% | — | — | 5 qtrssince 2019-Q3 | Unchanged 0 |
DISH NETWORK CORP-A | 3.6M | $105.1M | 3.3% | — | — | 5 qtrssince 2019-Q3 | Unchanged 0 |
INTERNATIONAL TOWER HILL MIN | 61.9M | $82.4M | 2.6% | $0.55 | +146.51% | 5 qtrssince 2019-Q3 | Increased 54 |
PACIRA BIOSCIENCES INC | 1.3M | $75.5M | 2.4% | $38.07 | +57.92% | 5 qtrssince 2019-Q3 | Decreased 0 |
KIRKLAND LAKE GOLD LTD | 1.5M | $73.1M | 2.3% | — | — | 3 qtrssince 2020-Q1 | Unchanged 0 |
TIFFANY & CO | 591,552 | $68.5M | 2.1% | — | — | 4 qtrssince 2019-Q4 | Decreased 0 |
ENDO INTERNATIONAL PLC | 14.5M | $47.8M | 1.5% | — | — | 5 qtrssince 2019-Q3 | Increased 65 |
VIACOMCBS INC | 1.6M | $44M | 1.4% | — | — | 4 qtrssince 2019-Q4 | Unchanged 0 |
| 1.5M | $43.5M | 1.4% | — | — | — | — | |
PRETIUM RESOURCES INC | 2.4M | $30.8M | 1.0% | — | — | 4 qtrssince 2019-Q4 | Unchanged 0 |
EQUINOX GOLD CORP | 2.5M | $29.3M | 0.9% | $11.17 | +4.37% | 2 qtrssince 2020-Q2 | Unchanged 0 |
TRILOGY METALS INC NEW | 14.3M | $25.6M | 0.8% | $1.67 | +9.58% | 5 qtrssince 2019-Q3 | Unchanged 0 |
PAULSON & CO. INC. manages $3.2B across 31 positions as of Q3 2020. Top holdings: HZNP (16.2%), BHC (12.5%), GLD (10.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Added 2 new positions, exited 1, increased 5, trimmed 6. Top move: ENDPQ (INCREASED, conviction 65). Portfolio: $3.2B across 31 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR